Siblings 圖書 [1/1] 會議論文/會議摘要 [2/2] 專利 [0/26] Collection Statistics 近3年內發表的文件:16(19.75%) 含全文筆數:80(98.77%) 文件下載次數統計 下載大於0次:80(100.00%) 下載大於100次:77(96.25%) 檔案下載總次數:43111(96.51%) 最後更新時間: 2024-12-12 07:21 Top Upload Loading... Top Download Loading... Recent Submissions Boosting DNA vaccine power by lipid... Effect of C-type lectin 16 on dengu... SARS-CoV-2 spike-FLIPr fusion prote... Lipid nanoparticle-encapsulated DNA... Co-delivery of a trimeric spike DNA... Mechanical transmission of dengue v... Recombinant lipidated FLIPr effecti... Omicron-specific mRNA vaccine induc... Formulation of SARS-CoV-2 spike pro... Glycosylation and S-palmitoylation ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-50 of 81. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2024-09-10	Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer	Molecular Therapy Nucleic Acids. 2024 Sep 10;35(3):Article number 102261.
2024-05-16	Effect of C-type lectin 16 on dengue virus infection in Aedes aegypti salivary glands	PNAS Nexus. 2024 May 16;3(5):Article number 188.
2024-03-14	Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters	Molecular Therapy Methods and Clinical Development. 2024 Mar 14;32(1):Article number 101169.
2024-02-01	SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters	Journal of Virology. 2024 Feb 20;98(2):Article number e0154623.
2023-08-27	Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2	Journal of Medical Virology. 2023 Aug 27;95(8):Article number e29040.
2023-08	Mechanical transmission of dengue virus by Aedes aegypti may influence disease transmission dynamics during outbreaks	eBioMedicine. 2023 Aug;Article number 104723.
2023-06-02	Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types	npj Vaccines. 2023 Jun 02;8:Article number 82.
2022-12-02	Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies	Journal of Medical Virology. 2022 Dec 2;95:Article number e28370.
2022-11-21	Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery	Pharmaceutics. 2022 Nov 21;14(11):Article number 2539.
2022-08-19	Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking	iScience. 2022 Aug 19;25(8):Article number 104709.
2022-06-09	Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy	Journal of Biomedical Science. 2022 Jun 9;29:Article number 37.
2022-06-03	A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection	npj Vaccines. 2022 Jun 03;7:Article number 60.
2022-05-02	Furin and TMPRSS2 resistant spike induces robust humoral and cellular immunity against SARS-CoV-2 lethal infection	Frontiers in Immunology. 2022 May 2;13:Article number 872047.
2022-04-28	Low-dose SARS-CoV-2 S-trimer with an emulsion adjuvant induced th1-biased protective immunity	International Journal of Molecular Sciences. 2022 Apr 28;23(9):Article number 4902.
2022-04-22	Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants	JCI Insight. 2022 Apr 22;7(8):Article number e157597.
2022-04	A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein	Vaccine. 2022 Apr;40(15):2299-2310.
2021-10-11	Intranasal vaccination with recombinant antigen-FLIPr fusion protein alone induces long-lasting systemic antibody responses and broad T cell responses	Frontiers in Immunology. 2021 Oct 11;12:Article number 751883.
2021-09-25	Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19	International Journal of Pharmaceutics. 2021 Sep 25;607:Article number 121024.
2021-09-10	Recombinant antigen of type 2 porcine reproductive and respiratory syndrome virus (Prrsv-2) promotes m1 repolarization of porcine alveolar macrophages and th1 type response	Vaccines. 2021 Sep 10;9(9):Article number 1009.
2021-07-12	A novel recombinant Fc gamma receptor-targeted survivin combines with chemotherapy for efficient cancer treatment	Biomedicines. 2021 Jul 12;9(7):Article number 806.
2021-05-27	DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss	PLoS Neglected Tropical Diseases. 2021 May 27;15(5):Article number e0009374.
2021-03-30	Aggressive organ penetration and high vector transmissibility of epidemic dengue virus-2 Cosmopolitan genotype in a transmission mouse model	PLoS Pathogens. 2021 Mar 30;17(3):Article number e1009480.
2020-09-29	Releasing intracellular NS1 from mosquito cells for the detection of dengue virus-infected mosquitoes	Viruses. 2020 Sep 29;12(10):Article number 1105.
2020-04-14	Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice	Journal of Biomedical Science. 2020 Apr 14;27:Article number 51.
2020-03-31	Immunodomination of serotype-specific CD4+ T-cell epitopes contributed to the biased immune responses induced by a tetravalent measles-vectored dengue vaccine	Frontiers in Immunology. 2020 Mar 31;11:Article number 546.
2019-12	A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses	Antiviral Research. 2019 Dec;172:Article number 104636.
2019-10	Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity	Biochemical and Biophysical Research Communications. 2019 Oct;517(4):596-602.
2019-08-02	Delivery of antigen to CD8(+) dendritic cells by fusing antigen with formyl peptide receptor-like 1 inhibitor protein induces antitumor immunity	Frontiers in Immunology. 2019 Aug 2;10:Article number 1839.
2019-03	Locally targeting the IL-17/ IL-17RA axis reduced tumor growth in a murine B16F10 melanoma model	Human Gene Therapy. 2019 Mar;3(3):273-285.
2018-04-23	Efficient uptake of recombinant lipidated survivin by antigen-presenting cells initiates antigen cross-presentation and antitumor immunity	Frontiers in Immunology. 2018 Apr 23;9:Article number 822.
2018-04-18	Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery	ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
2017-11-21	Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity	PLoS ONE. 2017 Nov 21;12(11):Article number e0188170.
2016-11-09	Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy	Scientific Reports. 2016 Nov 09;6:Article number 36732.
2016-07-29	Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice	Scientific Reports. 2016 Jul 29;6:Article number 30648.
2016-07	The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection	Human Vaccines and Immunotherapeutics. 2016 Jul;12(7):1678-1689.
2016-06	TGF-beta and IL-21 cooperatively stimulate activated CD8 T cells to differentiate into Tc17 cells	Immunology Letters. 2016 Jun;174:23-27.
2016-05	A toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population	Oncotarget. 2016 May;7(21):30804-30819.
2016-02	Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice	Vaccine. 2016 Feb;34(8):1054-1061.
2016-01	A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model	Oncotarget. 2016 Jan;7(1):671-683.
2015-12-29	The immunodominance change and protection of CD4+ T-cell responses elicited by an envelope protein domain III-based tetravalent dengue vaccine in mice	PLoS ONE. 2015 Dec 29;10(12):Article number e0145717.
2015-12	Recombinant bacterial lipoproteins as vaccine candidates	Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.
2015-10	Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy	OncoImmunology. 2015 Oct 29;5(3):e1095433.
2015-08-07	Recombinant lipoprotein-based vaccine candidates against C. difficile infections	Journal of Biomedical Science. 2015 Aug 7;22:Article number 65.
2015-06	Recombinant lipoproteins as novel vaccines with intrinsic adjuvant	Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
2014-09	A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus	Journal of General Virology. 2014 Sep;95(Pt 9):1983-1990.
2014-05	Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells	Journal of Immunology. 2014 May;192(9):4233-4241.
2014-03-19	Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy	Molecular Cancer. 2014 Mar 19;13:Article number 60.
2014-03	Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity	Vaccine. 2014 Mar;32(12):1346-1353.
2014-03	A purified recombinant lipopeptide as adjuvant for cancer immunotherapy	BioMed Research International. 2014 Mar;2014:Article number 349783.
2014-01	Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide	Biomaterials. 2014 Jan;35(5):1686-1695.

Showing items 1-50 of 81. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page